Evidence map›Paper›PMID 42474911›Full record

ArticleTranslational stroke research2026

Temporal Profile of Soluble TLR4 and its Association with Intracerebral Haemorrhage Expansion.

Maria Lucas-Parra, Carme Gubern-Mérida, Sofia Dávila, Tomàs Xuclà-Ferrarons, Joan Martínez, Saima Bashir, Alan Murillo, Víctor Vera-Monge, Juan Álvarez-Cienfuegos, Laia Carballo-Perich and 5 more

Abstract read
In one paragraph

Article in Translational stroke research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maria Lucas-Parra *Cerebrovascular Pathology Research Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Parc Hospitalari Martí i Julià, Edifici M2, Salt, 17190, Spain.ORCID http://orcid.org/0000-0002-2796-6732
Carme Gubern-Mérida *Cerebrovascular Pathology Research Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Parc Hospitalari Martí i Julià, Edifici M2, Salt, 17190, Spain.ORCID http://orcid.org/0000-0001-8378-4477
Sofia DávilaMedical student, University of Girona (UdG), Emili Grahit, 77, Girona, 17003, Spain.
Tomàs Xuclà-FerraronsStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-2986-5038
Joan MartínezStatistics Unit, Institut d'Investigació Biomèdica de Girona (IDIBGI- CERCA), Parc Hospitalari Martí i Julià, Edifici M2, Salt, 17190, Spain.ORCID http://orcid.org/0000-0003-2315-8436
Saima BashirStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-2019-467X
Alan MurilloStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-1818-3736
Víctor Vera-MongeStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-7039-7440
Juan Álvarez-CienfuegosStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0003-1604-2179
Laia Carballo-PerichCerebrovascular Pathology Research Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Parc Hospitalari Martí i Julià, Edifici M2, Salt, 17190, Spain.ORCID http://orcid.org/0000-0002-1843-7660
Elisabet OrtizStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-1917-6132
Isabel Vielba-GomezStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.
Joaquín SerenaStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-4478-7744
Mikel TerceñoStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain. mterceno.girona.ics@gencat.cat.ORCID http://orcid.org/0000-0001-5532-5329
Yolanda SilvaStroke Unit, Department of Neurology, Cerebrovascular Pathology Research Group, University Hospital Doctor Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), RICORS-ICTUS, Av. França s/n (7a planta), Girona, 17007, Spain.ORCID http://orcid.org/0000-0002-9450-8918

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation contributes to haematoma expansion (HE) and poor prognosis in spontaneous intracerebral haemorrhage (ICH). This study aimed to characterise the temporal profile of soluble Toll-like receptor 4 (sTLR4) during the hyperacute and acute phases of ICH and to evaluate its association with HE. Serum sTLR4 levels were measured at admission, 24 and 72 h from 99 patients with primary hemispheric ICH within 12 h of symptom onset, and at baseline from 39 non-stroke controls using enzyme-linked immunosorbent assay (ELISA). Longitudinal sTLR4 fluctuations were evaluated through linear mixed-effects models. Independent HE prognosticators were identified using multivariable logistic regression, and model performance was assessed via the area under the receiver operating characteristic curve (AUC-ROC). ICH patients exhibited significantly higher baseline sTLR4 levels than controls, which declined over time and were not associated with clinical variables. Notably, patients with HE demonstrated higher admission sTLR4 levels than those without HE (2.50 [95% CI: 1.84-3.16] vs. 1.62 [95% CI: 1.22-2.02] ng/mL, p = 0.027). Furthermore, while the non-HE group showed a rapid decrease within the first 24 h, the HE group maintained elevated levels with a more gradual decline. A multivariable model incorporating baseline ICH volume and sTLR4 levels achieved an AUC of 0.829, with positive and negative predictive values of 70.8% and 90.1%, respectively. These findings suggest that TLR4 may be involved in the pathophysiology of HE, and the combination of baseline ICH volume and sTLR4 levels could serve as a useful tool to stratify patients into low- and high-risk groups for HE.

Indexed as

Cerebral HemorrhageToll-Like Receptor 4AgedAged, 80 and overBiomarkersFemaleHumansMaleMiddle AgedPrognosisROC CurveBiomarkersTLR4 protein, humanToll-Like Receptor 4BiomarkersHaematoma expansionIntracerebral haemorrhagePrognosisSoluble toll-like receptor 4

Identifiers

PMID42474911
PMCPMC13385087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.